Alignment with US Food and Drug Administration on a Recommended Phase 2 Dose for NVL-520 of 100 mg daily CAMBRIDGE, Mass., Sept. 5, 2023 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for…
Zixi and Partner Ecosystem Delivering Next-Gen, Cutting-Edge Deployments WALTHAM, Mass., Sept. 5, 2023 /PRNewswire/ — Zixi, the industry leader for enabling cost-efficient and highly scalable live broadcast-quality video over any IP network or protocol, and the provider of the…
CAMBRIDGE, England, Sept. 5, 2023 /PRNewswire/ — Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that Young Kwon, PhD, Chief Executive Officer, will participate in a fireside chat at…
TAIPEI, Sept. 4, 2023 /PRNewswire/ — BizLink (TWSE code: 3665), a major global interconnect solutions provider, is happy to announce that we have won the Asiamoney 2023 Asia’s Outstanding Companies Poll in the “Most Outstanding Company in Taiwan – Automobiles & Components Sector” for the…
While the portfolio is available for divestment or licensing, all offers will be evaluated on their merits and whether to transact will be determined on a case-by-case basis.
Early discussions with GTT Group are recommended. Preference is provided to those parties that enter into or have pre-existing non-notice NDA’s in place and have the ability to transact within a three to four month time period. Please contact GTT Group for further information and details. GTT Group can be reached at [email protected].
All inquiries will be kept strictly confidential. GTT Group’s transaction specialists and subject matter experts are available to discuss the portfolio and market applicability. Upon review of the portfolio, indications of interest should be submitted as soon as possible to GTT Group’s designated contact.
About Global Technology Transfer Group, Inc. GTT Group’s storied history includes Nortel and AOL transactions and it is proud to continue this tradition with the current offering to select pre-qualified parties. Global Technology Transfer Group, Inc. is a world leading patent transaction advisory & consultancy firm. GTT Group combines core competencies in patent analysis, valuation, transactions, and market knowledge to deliver unparalleled results. The company’s corporate headquarters are in Portland, Oregon.
HANGZHOU and SHAOXING, China, Sept. 4, 2023 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces today that it will participate in the upcoming Morgan Stanley 21st Annual Global Healthcare Conference. John Gargiulo, Chief Business Officer of Ascletis, will join the…
Colaboradores en Ecuador, República Dominicana, Panamá y Miami se han adherido al proyecto en la primera edición de Bupa Global Latinoamérica El reto consiste en caminar 6.000 pasos diarios durante un mes Por cada empleado que cumpla el reto, Bupa plantará árboles y ampliará su programa…
Event attendees will have the opportunity to make a tax-deductible donation to Wellness Together School Mental Health, a California-based, national 501(c)(3) nonprofit corporation aiming to increase mental health awareness, advocacy, and access. Donations to Wellness Together support student mental health services.
WHEN: Thursday, September 7, 2023 7:30 pm – 9:30 pm PT *Doors open at 6:30 pm PT WHERE: Anaheim Convention Center 800 W Katella Ave, Anaheim, CA 92802
WHO:Chris Gethard, Nicole Byer, Aparna Nancherla, Eddie Pepitone, and more.
COST:FREE! Attendees may need to pay for parking. Onsite cash bar available. For more information or to get tickets, visit:
GRAND BLANC, Mich., Sept. 4, 2023 /PRNewswire/ — ModuleMD, a leading healthcare technology and services company, announced today that it has acquired Diversified Health Care Management, Inc. (“Diversified”) and MedEase Practice Management software (DBA Professional Management Services,…
The program is a part of the Seegene OneSystemTM business aimed at creating a ‘world free from all diseases’ Collaborating with clinical researchers worldwide, Seegene will share its technologies and enable researchers to develop syndromic qPCR assays SEOUL, South Korea, Sept. 4, 2023…